Daily Ards Research Analysis
Today's ARDS-focused research spans translational neuroimmune modulation and clinical phenotyping. A preclinical study shows electroacupuncture mitigates intestinal ischemia–reperfusion–induced lung injury via a vagus–sympathetic pathway, while a multicenter cohort identifies two distinct ARDS phenotypes after hematopoietic cell transplantation with divergent outcomes and a simple six-variable classifier.
Summary
Today's ARDS-focused research spans translational neuroimmune modulation and clinical phenotyping. A preclinical study shows electroacupuncture mitigates intestinal ischemia–reperfusion–induced lung injury via a vagus–sympathetic pathway, while a multicenter cohort identifies two distinct ARDS phenotypes after hematopoietic cell transplantation with divergent outcomes and a simple six-variable classifier.
Research Themes
- Neuroimmune modulation in acute lung injury
- ARDS phenotyping in immunocompromised hosts
- Translational pathways from autonomic regulation to lung protection
Selected Articles
1. Electroacupuncture alleviates intestinal ischemia-reperfusion-induced acute lung injury via the vagus-sympathetic nerve pathway.
In a rat II/R model, electroacupuncture attenuated intestinal and lung injury, strengthened epithelial and endothelial barrier proteins (Claudin-5, ZO-1), reduced BALF protein, and increased surfactant proteins (SP-A, SP-D). It shifted autonomic balance toward parasympathetic signaling with increased acetylcholine, VIP, and lung α7nAChR; protection was abolished by vagotomy and attenuated by sympathectomy.
Impact: This study provides mechanistic evidence linking autonomic modulation to lung protection in II/R-induced injury, suggesting a testable neuroimmune pathway for intervention. It integrates physiological, molecular, and surgical denervation approaches to establish causality.
Clinical Implications: While preclinical, findings support exploring vagus-mediated neuromodulation (e.g., auricular vagus stimulation or acupuncture-based strategies) as adjunctive therapies to reduce lung injury from abdominal ischemia-reperfusion.
Key Findings
- Electroacupuncture reduced intestinal and lung histopathology and edema after II/R and increased barrier proteins Claudin-5 and ZO-1.
- BALF total protein decreased and surfactant proteins SP-A and SP-D increased with electroacupuncture.
- Autonomic balance shifted toward parasympathetic activity: increased acetylcholine, VIP in mesenteric nodes, lung α7nAChR; LF/HF ratio decreased.
- Protective effects were abolished by vagotomy and partially blunted by chemical sympathectomy, implicating the vagus–sympathetic pathway.
- HPA axis mediators and the peripheral glutamate/GABA ratio decreased with electroacupuncture.
Methodological Strengths
- Mechanistic validation using both vagotomy and chemical sympathectomy to dissect autonomic pathways
- Multimodal endpoints spanning histology, barrier proteins, BALF proteins, surfactant proteins, HRV metrics, and neurohumoral markers
Limitations
- Preclinical rat model without human validation limits immediate translational applicability
- Unclear dose–response, timing windows, and long-term outcomes for electroacupuncture
Future Directions: Validate autonomic signatures and efficacy in large-animal models and early-phase human studies; test noninvasive vagal modulation strategies and define optimal dosing/timing.
AIMS: Intestinal ischemia-reperfusion (II/R) injury predominantly causes acute lung injury (ALI), and in severe instances, acute respiratory distress syndrome, both associated with high mortality. Electroacupuncture (EA) excels in regulating autonomic nervous system balance and safeguarding organ function. This study delved into EA's impacts and mechanisms on II/R-induced ALI. METHODS AND RESULTS: A rat II/R model was created by occluding the superior mesenteric artery for 1 h followed by reperfusion, with EA stimulation applied 30 min before reperfusion. Vagotomy and chemical sympathectomy explored EA's link with the autonomic nervous system. Findings revealed EA mitigated II/R-induced intestinal and lung pathological damage and edema, increased Claudin-5 and ZO-1 expression, inhibited local and systemic inflammation. Additionally, EA reduced the total protein concentration in bronchoalveolar lavage fluid while increasing the levels of pulmonary surfactant related proteins SP-A and SP-D, and decreased the low/high frequency ratio of heart rate variability. EA enhanced central parasympathetic activity, peripheral acetylcholine, vasoactive intestinal peptide in mesenteric lymph nodes, and lung α7nAChR expression, while reducing hypothalamic-pituitary-adrenal axis substances and peripheral blood glutamic acid/γ-aminobutyric acid ratio. However, the protective effect of EA disappeared after vagotomy in rats and partially weakened after sympathetic nerve chemical resection. CONCLUSION: EA alleviates II/R-ALI via the vagus-sympathetic nerve pathway, highlighting its therapeutic potential.
2. Acute Respiratory Distress Syndrome Phenotypes After Stem Cell Transplantation: A Latent Class Analysis.
Multicenter retrospective LCA of 166 HCT recipients with ARDS identified two phenotypes: a later-onset, hyperbilirubinemic, hypercapnic, more hypoxemic class with worse 90-day mortality, and an earlier, neutropenia/PERDS-enriched class. A six-variable model achieved high classification accuracy, enabling pragmatic bedside stratification.
Impact: Defines clinically meaningful ARDS phenotypes in a high-risk HCT population using routinely available variables, laying groundwork for targeted interventions and trial enrichment.
Clinical Implications: Supports phenotype-aware management and trial design in post-transplant ARDS; the six-variable classifier could aid early risk stratification and tailored supportive strategies.
Key Findings
- Two ARDS phenotypes after HCT were identified via latent class analysis across three centers.
- Class 1 had worse hypoxemia, higher Pco2 and bilirubin, occurred later post-transplant, and had higher 90-day mortality (72.8% vs 48.2%).
- Class 2 was associated with neutropenia and peri-engraftment respiratory distress syndrome; an exploratory six-variable model classified classes with accuracy 0.90.
Methodological Strengths
- Multicenter cohort with objective model selection metrics (BIC, entropy, VLMR-LRT)
- Parsimonious classifier using routine variables enabling external validation
Limitations
- Retrospective design with potential residual confounding and selection bias
- Lack of external validation and absence of biological markers limits mechanistic inference
Future Directions: External validation and prospective implementation of the six-variable classifier; integrate biomarkers/cytokines to map phenotypes to underlying biology and guide targeted therapies.
OBJECTIVE: To identify distinct phenotypes of acute respiratory distress syndrome (ARDS) developing after hematopoietic cell transplantation (HCT), using routinely available clinical data at ICU admission. DESIGN: Multicenter retrospective cohort study using latent class analysis. SETTING: ICUs across three Mayo Clinic campuses (Minnesota, Florida, and Arizona). PATIENTS: A total of 166 adult patients who developed ARDS within 120 days following HCT (96 allogeneic, 70 autologous). INTERVENTION: None. MEASUREMENTS AND MAIN RESULTS: Model selection was based on multiple metrics including Bayesian information criteria, entropy, and Vuong-Lo-Mendell-Rubin Likelihood Ratio testing. A two-class model optimally described the cohort. Class 1 (n = 81) was characterized by worse hypoxemia (P/F ratio 157 vs. 210, p = 0.002), higher Pco2 (41 vs. 36 mm Hg, p < 0.001), and higher bilirubin (1.4 vs. 0.9 mg/dL, p < 0.001) compared with class 2 (n = 85). Both classes included a mix of transplant types, transcending a simple autologous/allogeneic dichotomy, although class 1 had more allogeneic recipients (70.4% vs. 45.9%, p = 0.001). Although time-from-transplant was not a class-defining variable, class 1 occurred later after transplant (30.0 vs. 11.9 d, p < 0.001) with higher frequency of idiopathic pneumonia syndrome (14.8% vs. 2.4%, p = 0.004). Class 2 had more frequent neutropenia (leukocytes 0.4 vs. 5.9 × 109, p < 0.001) and higher frequency of peri-engraftment respiratory distress syndrome (29.4% vs. 9.9%, p = 0.005). Outcomes were significantly worse for class 1 (90-d mortality: 72.8% vs. 48.2%, p = 0.001). An exploratory parsimonious model had good classification accuracy (0.90) using just six variables: leukocyte count, platelet count, bilirubin, Pco2, body mass index, and temperature. CONCLUSIONS: ARDS after HCT comprises two distinct phenotypes with distinct clinical characteristics and outcomes. These phenotypes align with recognized post-HCT lung injury syndromes and may reflect different underlying biological processes. This framework provides a foundation for investigating targeted therapeutic approaches.